Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab

International Urology and Nephrology

Volumn 40, Issue 3, 2008, Pages 807-810

  Suri, Megha ^a   Tran, Kim ^b   Sharma, Ajay P ^a   Filler, Guido ^a   Grimmer, Joanne ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Ciclosporin induced atypical hemolytic uremic syndrome; FSGS; Mycophenolate mofetil; Plasma exchange; Rituximab; Steroid resistant nephrotic syndrome

Indexed keywords

ALBUMIN; AMLODIPINE; CHOLESTEROL; CORTICOSTEROID DERIVATIVE; COTRIMOXAZOLE; CYCLOSPORIN A; DEXAMETHASONE; ENOXAPARIN; FUROSEMIDE; HYDROCHLOROTHIAZIDE; IMMUNOGLOBULIN; LABETALOL; LOSARTAN; MINOXIDIL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEPHRIN; NIFEDIPINE; PENICILLIN V; PODOCIN; PREDNISOLONE; RAMIPRIL; RITUXIMAB; SPIRONOLACTONE; TACROLIMUS;

ABSENCE OF SIDE EFFECTS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG INFUSION; DRUG WITHDRAWAL; FOCAL GLOMERULOSCLEROSIS; GENETIC ANALYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; INFANT; KIDNEY BIOPSY; LUNG EMBOLISM; MALE; MULTIPLE CYCLE TREATMENT; NEPHROTIC SYNDROME; PLASMAPHERESIS; PNEUMOCYSTIS PNEUMONIA; PROTEINURIA; REMISSION; THROMBOCYTOPENIA;

ANTIBODIES, MONOCLONAL; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; NEPHROTIC SYNDROME; REMISSION INDUCTION; STEROIDS;

EID: 48549093428     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-008-9393-0     Document Type: Article

References (28)

1. Borges FF, Shiraichi L, da Silva MP, Nishimoto EI, Nogueira PC (2007) Is focal segmental glomerulosclerosis increasing in patients with nephrotic syndrome? Pediatr Nephrol 22:1309-1313
2. Filler G, Young E, Geier P, Carpenter B, Drukker A, Feber J (2003) Is there really an increase in non-minimal change nephrotic syndrome in children? Am J Kidney Dis 42:1107-1113
3. Cattran DC, Appel GB, Hebert LA et al (1999) A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int 56:2220-2226
4. Cattran DC (2003) Cyclosporine in the treatment of idiopathic focal segmental glomerulosclerosis. Semin Nephrol 23:234-241
5. Bhimma R, Adhikari M, Asharam K, Connolly C (2006) Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus. Am J Nephrol 26:544-551
6. Westhoff TH, Schmidt S, Zidek W, Beige J, Van der Giet M (2006) Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome. Clin Nephrol 65:393-400
7. Ciechanska E, Segal L, Wong H, Chretien C, Feber J, Filler G (2005) Plasma exchange using a continuous venovenous hemofiltration machine in children. Blood Purif 23:440-445
8. Multicenter clinical trial of focal glomerulosclerosis in children and young adults. http://www.niddk.nih.gov/patient/fsgs/fsgs.htm#3, http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-02-013.html
9. Pandirikkal VB, Jain M, Gulati S (2007) Tacrolimus-induced HUS: An unusual cause of acute renal failure in nephrotic syndrome. Pediatr Nephrol 22:298-300
10. Bagga A, Sinha A, Moudgil A (2007) Rituximab in patients with the steroid-resistant nephrotic syndrome. N Engl J Med 356:2751-2752
11. Benz K, Dötsch J, Rascher W, Stachel D (2004) Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol 19:794-797
12. Smith GC (2007) Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome? Pediatr Nephrol 22:893-898
13. Gilbert RD, Hulse E, Rigden S (2006) Rituximab therapy for steroid-dependent minimal change nephrotic syndrome. Pediatr Nephrol 21:1698-1700
14. Cattran DC, Wang MM, Appel G, Matalon A, Briggs W (2004) Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis. Clin Nephrol 62:405-411
15. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F (1996) Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334:878-883
16. Savin VJ, McCarthy ET, Sharma M (2003) Permeability factors in focal segmental glomerulosclerosis. Semin Nephrol 23:147-160
17. Salama AD, Pusey CD (2006) Drug insight: Rituximab in renal disease and transplantation. Nat Clin Pract Nephrol 2:221-230
18. Pescovitz MD (2006) Rituximab, an anti-CD20 monclonal antibody: History and mechanism of action. Am J Transplant 6:859-866
19. Klastersky J (2006) Adverse effects of the humanized antibodies used as cancer therapeutics. Curr Opin Oncol 18:316-320
20. Rey J, Belmecheri N, Bouayed N, Ivanov V, Coso D, Gastaut JA, Bouabdallah R (2007) JC papovavirus leukoencephalopathy after first line treatment with CHOP and rituximab. Haematologica 92(10):e101
21. Freim Wahl SG, Folvik MR, Torp SH (2007) Progressive multifocal leukoencephalopathy in a lymphoma patient with complete remission after treatment with cytostatics and rituximab: Case report and review of the literature. Clin Neuropathol 26(2):68-73
22. Remuzzi G, Chiurchiu C, Abbate M, Brusegan V, Bontempelli M, Ruggenenti P (2002) Rituximab for idiopathic membranous nephropathy. Lancet 360:923-924
23. Cobo M, Hernández D, Rodriguez C, Pérez-Tamajón L (2006) Successful therapeutic use of rituximab in refractory membranous glomerulonephritis. Clin Nephrol 66:54-57
24. François H, Daugas E, Bensman A, Ronco P (2007) Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: First case report and pathophysiological considerations. Am J Kidney Dis 49:158-161
25. Hofstra JM, Deegens JK, Wetzels JF (2007) Rituximab: Effective treatment for severe steroid-dependent minimal change nephrotic syndrome? Nephrol Dial Transplant 22:2100-2102
26. Yang T, Nast CC, Vo A, Jordan SC (2008) Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy. Nephrol Dial Transplant 23:377-380
27. Salama AD, Pusey CD (2006) Drug insight: Rituximab in renal disease and transplantation. Nat Clin Pract Nephrol 2:221-230
28. Sheashaa H, Mahmoud I, El-Basuony F, El-Husseini A, Hassan N, El-Baz M, Ahmed NS, Sobh M (2007) Does cyclosporine achieve a real advantage for treatment of idiopathic nephrotic syndrome in children? A long-term efficacy and safety study. Int Urol Nephrol 39:923-928